Search results
Small Business - Picayune Item | Picayune Item
The Picayune Item· 7 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide ...
Glucocorticoid-induced osteoporosis: An overview
Medical News Today· 2 days agoGlucocorticoids are a class of drugs that can reduce inflammation or immune system activity. This can result in glucocorticoid-induced osteoporosis....
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
The Pilot News· 7 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide ...